|
|
| (11) | Number of the document | C 1463716 |
| (68) | Number of the document | 1463716 |
| (21) | Application number for Supplementary Protection Certificate | PA 2017 032 |
| (22) | Date of filing the application | 2017-10-16 |
| (41) | Date of publication of the application | 2017-11-10 |
| Date of publication of SPC | 2018-06-25 | |
| (24) | Date of coming into effect of SPC | 2022-12-18 |
| (71) |
TESARO, Inc.,
1000 Winter St.North, Waltham MA 02451,
US
|
| (73) |
TESARO, Inc.,
1000 Winter St.North, Waltham MA 02451,
US
|
| (74) |
Genė Ona SRUOGIENĖ,
UAB TARPINĖ, A.P.Kavoliuko g. 24-152, LT-04328 Vilnius,
LT
|
| (93) | EU/1/17/1180/001, 2017-04-20 |
| (94) | 2027-12-17 |
| (95) | Rolapitantas, pasirinktinai farmaciniu požiūriu priimtinos druskos formos, įskaitant rolapitanto hidrochlorido monohidratą |
| SPC lapsed (non-payment of fees for the main patent) |